β¨ Medicine Approvals and Lottery Permission
9 DECEMBER NEW ZEALAND GAZETTE 4477
Product: Flameril Retard.
Active Ingredient(s): Diclofenac sodium 100 mg.
Dosage Form: Modified release tablet.
NZ Sponsor: Novartis New Zealand Limited.
Manufacturer(s): Laboratorio Normal Produtos Farmaceuticos SA, Alto do Forte, Casais de Mem Martins, Rio de Mouro, Portugal.
Product: Flameril Retard.
Active Ingredient(s): Diclofenac sodium 75 mg.
Dosage Form: Modified release tablet.
NZ Sponsor: Novartis New Zealand Limited.
Manufacturer(s): Laboratorio Normal Produtos Farmaceuticos SA, Alto do Forte, Casais de Mem Martins, Rio de Mouro, Portugal.
Product: Risperdal.
Active Ingredient(s): Risperidone 0.25 mg.
Dosage Form: Film coated tablet.
NZ Sponsor: Janssen-Cilag Pty Limited.
Manufacturer(s): Janssen Pharmaceutica NV, Plant 2, Beerse, Belgium.
Janssen-Cilag SpA, Via C. Janssen, Borgo San Michele, Latina, Italy.
Product: Risperdal.
Active Ingredient(s): Risperidone 0.5 mg.
Dosage Form: Film coated tablet.
NZ Sponsor: Janssen-Cilag Pty Limited.
Manufacturer(s): Janssen Pharmaceutica NV, Plant 2, Beerse, Belgium.
Janssen-Cilag SpA, Via C. Janssen, Borgo San Michele, Latina, Italy.
Product: Vancomycin.
Active Ingredient(s): Vancomycin hydrochloride 1030 mg equivalent to 1000 mg vancomycin.
Dosage Form: Powder for infusion.
NZ Sponsor: Pacific Pharmaceuticals Limited.
Manufacturer(s): Lipha SA, Le Pressoir Vert, Semoy, France.
Product: Vancomycin.
Active Ingredient(s): Vancomycin hydrochloride 515 mg equivalent to 500 mg vancomycin.
Dosage Form: Powder for infusion.
NZ Sponsor: Pacific Pharmaceuticals Limited.
Manufacturer(s): Lipha SA, Le Pressoir Vert, Semoy, France.
Dated this 1st day of December 1999.
S. S. JESSAMINE, Acting Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
89170
Internal Affairs
Gaming and Lotteries Act 1977
Permission to Conduct Within New Zealand a Lottery Promoted Outside New Zealand
Pursuant to section 69 of the Gaming and Lotteries Act 1977, I, Jack Elder, Minister of Internal Affairs, hereby permit Nestle Australia Limited, to conduct within New Zealand, subject to the conditions specified in the Schedule to this notice, a lottery promoted outside New Zealand as a sales promotion scheme, to promote the sale of the products from the Nestle, Friskies and Allens range.
Schedule
Conditions
The permission given by this notice is subject to the following conditions, namely:
(1) Nestle Australia Limited shall not conduct the sales promotion scheme limited in New Zealand after 31 July 2000;
(2) The results of the sales promotion scheme shall be published in the New Zealand Herald on the 18th day of August 2000;
Winners will be notified by certified mail;
(3) New Zealand winners shall not be subject to any extra cost when they claim their prizes;
(4) The chance of a New Zealand participant winning a prize shall be equal to that of an overseas participant.
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1999, No 189
NZLII —
NZ Gazette 1999, No 189
β¨ LLM interpretation of page content
π₯ Approval of Flameril Retard (100 mg)
π₯ Health & Social Welfare1 December 1999
Medicine, Flameril Retard, Diclofenac sodium, Modified release tablet, Novartis New Zealand Limited, Laboratorio Normal Produtos Farmaceuticos SA
- S. S. Jessamine, Acting Chief Advisor, Safety and Regulation
π₯ Approval of Flameril Retard (75 mg)
π₯ Health & Social Welfare1 December 1999
Medicine, Flameril Retard, Diclofenac sodium, Modified release tablet, Novartis New Zealand Limited, Laboratorio Normal Produtos Farmaceuticos SA
- S. S. Jessamine, Acting Chief Advisor, Safety and Regulation
π₯ Approval of Risperdal (0.25 mg)
π₯ Health & Social Welfare1 December 1999
Medicine, Risperdal, Risperidone, Film coated tablet, Janssen-Cilag Pty Limited, Janssen Pharmaceutica NV, Janssen-Cilag SpA
- S. S. Jessamine, Acting Chief Advisor, Safety and Regulation
π₯ Approval of Risperdal (0.5 mg)
π₯ Health & Social Welfare1 December 1999
Medicine, Risperdal, Risperidone, Film coated tablet, Janssen-Cilag Pty Limited, Janssen Pharmaceutica NV, Janssen-Cilag SpA
- S. S. Jessamine, Acting Chief Advisor, Safety and Regulation
π₯ Approval of Vancomycin (1000 mg)
π₯ Health & Social Welfare1 December 1999
Medicine, Vancomycin, Vancomycin hydrochloride, Powder for infusion, Pacific Pharmaceuticals Limited, Lipha SA
- S. S. Jessamine, Acting Chief Advisor, Safety and Regulation
π₯ Approval of Vancomycin (500 mg)
π₯ Health & Social Welfare1 December 1999
Medicine, Vancomycin, Vancomycin hydrochloride, Powder for infusion, Pacific Pharmaceuticals Limited, Lipha SA
- S. S. Jessamine, Acting Chief Advisor, Safety and Regulation
π Permission to Conduct Lottery
π Trade, Customs & IndustryLottery, Gaming and Lotteries Act 1977, Nestle Australia Limited, Sales promotion, New Zealand Herald
- Jack Elder, Minister of Internal Affairs